Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange Detected- The page now shows a new Revision: v3.5.4, replacing the prior v3.5.3, indicating a software version bump. This change reflects an internal update to the site rather than a modification to study information.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows Revision: v3.5.3 instead of Revision: v3.5.2. This reflects a minor update to the page's content or presentation.SummaryDifference0.0%

- Check46 days agoChange DetectedThe site version was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.5.0. Deleted Revision: v3.4.3.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision updated to v3.4.3 (from v3.4.2).SummaryDifference0.0%

- Check111 days agoChange DetectedThe page adds a reference to Primary peritoneal carcinoma and a Genetic and Rare Diseases Information Center resource, and removes the government funding notice. A revision note (v3.4.2) is also shown.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.